With our research team’s detailed analysis of the ecosystem, our investors understand the markets and clearly see why, when, which, and how much stock to buy and sell. Daily Stock Market Outlook Report by Imperial Money Pvt. Ltd. of 20th May, 2022. Download Free Report Now!!!

1. MARKET OUTLOOK REPORT
Figure. Nifty50 Intraday chart
Index Previous close Open High Low Close Change %
Nifty 50 15,809.40 16,043.80 16,283.05 16,003.85 16,266.15 2.89%
Sensex 52,792.23 53,513.97 54,396.43 53,403.29 54,326.39 2.91%
Nifty opened with positive
gap up today at 16,043.8
on 20th
May 2022, index
was very bullish and made
a day high of 16,283.05 and
closed positive at very
important level 16,266.15
Resistance for nifty is
16,600 and support is
15,400 (Closing Basis). Nifty
may test 18800 in coming
days.
www.imperialfin.com wecare@imperialfin.com +91-9595889988
20th
May 2022

2. Sectorial Performance
2.14%
1.54%
3.69%
2.57%
2.88%
2.79%
0.59%
4.21%
4.20%
NIFTYFMCG
NIFTYIT
NIFTYPHARMA
NIFTYFINSERVICE
NIFTYBANK
NIFTYAUTO
NIFTYMEDIA
NIFTYREALTY
NIFTYMETAL
SECTORS CHANGE %
SECTORS CHANGE %
www.imperialfin.com wecare@imperialfin.com +91-9595889988
20th
May 2022

3. Top Trending News
 MEP INFRASTRUCTURE DEVELOPERS:
CO SAYS STEP-DOWN UNIT BHALAJI TOLL ROAD GETS LETTER OF AWARD FROM NHAI || DAILY REMITTANCE FOR PROJECT
IS 5M RUPEES
 SEBI:
SAYS MARKET INFRASTRUCTURE INSTITUTIONS MII SHOULD MAINTAIN UP-TO-DATE INVENTORY OF ITS HARDWARE AND
SYSTEMS, SOFTWARE AND INFORMATION ASSETS || SEBI SAYS ANY GAPS/VULNERABILITIES DETECTED HAVE TO BE
REMEDIED ON IMMEDIATE BASIS
 HINDUSTAN FOODS:
CO APPROVES STOCK SPLIT IN RATIO 5:1 (CO APPROVED THE PROPOSAL OF SUB-DIVISION/SPLIT OF EXISTING 1 (ONE)
EQUITY SHARE EACH FULLY PAID UP INTO 5 (FIVE) EQUITY SHARES)
 IIFL WEALTH MANAGEMENT:
BOARD MEETING ON MAY 25 TO CONSIDER DECLARATION OF FIRST INTERIM DIVIDEND FOR THE FINANCIAL YEAR 2022-23
 RUSSIAN:
GAS FLOW TO FINLAND WILL BE HALTED ON MAY 21 AT 0400 GMT, FINNISH ENERGY COMPANY GASUM SAYS
 GLENMARK PHARMACEUTICALS:
CO RECEIVES TENTATIVE ANDA APPROVAL FOR CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE FOAM || IT HAS US
SALES OF USD 115M
20th
May 2022
www.imperialfin.com wecare@imperialfin.com +91-9595889988

4. 4.68%
1.89% 1.81%
1.09% 0.97%
0.00%
1.00%
2.00%
3.00%
4.00%
5.00%
GODREJCP ADANIGREEN PIIND GLAND SHREECEM
TOP LOSERS
8.13%
6.71%
5.83% 5.83% 5.43%
0.00%
2.00%
4.00%
6.00%
8.00%
10.00%
DRREDDY AUROPHARMA BOSCHLTD RELIANCE BIOCON
TOP GAINERS
Stocks in Action
www.imperialfin.com wecare@imperialfin.com +91-9595889988
20th
May 2022

5. Corporate Actions
 Tantia Constructions Limited (AGM on 23rd
May)
 Coforge Limited (Interim Dividend Rs 13/- Per Share on 23rd
May)
FII/DII/FPI ACTION IN CAPITAL MARKET
Category Date Buy Value Sell Value Net Value
DII 19 May 2022 7414.25 cr 4188.71 cr 3225.54 cr
FII/FPI 19 May 2022 6389.87 cr 11289.79 cr -4899.92 cr
 The following is combined Domestic Institutional Investors trading data across NSE, BSE and MSEI
collated on the basis of trades executed by Banks, DFIs, Insurance, MFs and New Pension System.
20th
May 2022
www.imperialfin.com wecare@imperialfin.com +91-9595889988

6. SUNPHARMA. Sector:Pharma.
Important Parameter
MARKET CAP P/B EPS BOOK VALUE PE ROE ROCE
1,59,702.99
CR
2.43 23.72 94.27 9.65 23.02% 12.03%
FUNDAMENTALS.
 Company has been maintaining healthy ROE of 22.73% over the past 3 years.
 The Company has been maintaining an effective average operating margins of 87.06% in the last 5 years.
 Company’s PEG ratio is 0.93.
 The company has an efficient Cash Conversion Cycle of 54.52 days.
 The company has a good cash flow management; CFO/PAT stands at 2.54.
 The company has a high promoter holding of 51.34%.
Stock Entry price Positional
target
SUNPHARMA 900 1020
www.imperialfin.com wecare@imperialfin.com +91-9595889988
20th
May 2022

7. Disclaimer
This document has been prepared for IMPERIAL MONEY PVT. LTD. by Mr. Praveen Dubey NISM (201800048686) is a Research Consultant for Imperial Money Pvt. Ltd. This Market Outlook is
intended for use only by the person or entity to which it is addressed to. This Document may contain confidential and/or privileged material and is not for any type of circulation and any
review, retransmission, or any other use is strictly prohibited. This Document is subject to changes without prior notice. This document does not constitute an offer to sell or solicitation for the
purchase or sale of any financial instrument or as an official confirmation of any transaction. Though disseminated to all customers who are due to receive the same, not all customers may
receive this report at the same time. Imperial Money Pvt. Ltd. Does not carry any responsibility in case to whomsoever using the information of this newsletter content and data
www.imperialfin.com wecare@imperialfin.com +91-9595889988
20th
May 2022